NasdaqGS:BIIBBiotechs
Biogen (BIIB) Stock Revenue Holds While Margins and EPS Retreat
Biogen stock was slightly softer heading into the weekend, off about 0.6% on Friday and roughly flat over the past week. This signals investors were cautious rather than euphoric about this earnings print. The numbers explain why. Q2 revenue landed at US$2.7b, while basic earnings per share dropped to US$0.66 from US$2.17 in Q1, keeping the spotlight firmly on a margin squeeze that has already pulled trailing net profit margins down to 8.3% from 15.3% last year.
Is Biogen a genuine bargain at...